Fewer COVID Vaccine Doses Materialized Last Fall Than The U.S. Government Hoped

Sydney Lupkin, NPR's pharmaceuticals correspondent, dives into the complexities of Operation Warp Speed's vaccine rollout. She reveals how Pfizer initially delivered fewer COVID vaccine doses than expected, leaving federal officials perplexed. Lupkin discusses the unpredictable hurdles in mass production and highlights the impact of supply chain issues. The conversation also touches on the critical importance of transparency and communication between the government and pharmaceutical companies, emphasizing lessons learned for future public health responses.